"10.1371_journal.pone.0038661","plos one","2012-06-29T00:00:00Z","Claire Meyniel; Timothy Spelman; Vilija G Jokubaitis; Maria Trojano; Guillermo Izquierdo; François Grand’Maison; Celia Oreja-Guevara; Cavit Boz; Alessandra Lugaresi; Marc Girard; Pierre Grammond; Gerardo Iuliano; Marcela Fiol; Jose Antonio Cabrera-Gomez; Ricardo Fernandez-Bolanos; Giorgio Giuliani; Jeannette Lechner-Scott; Edgardo Cristiano; Joseph Herbert; Tatjana Petkovska-Boskova; Roberto Bergamaschi; Vincent van Pesch; Fraser Moore; Norbert Vella; Mark Slee; Vetere Santiago; Michael Barnett; Eva Havrdova; Carolyn Young; Carmen-Adella Sirbu; Mary Tanner; Michelle Rutherford; Helmut Butzkueven; on behalf of the MSBasis Study Group","Department of Neurology, Royal Melbourne Hospital, Victoria, Australia; CHU Nantes, CIC 0004, Nantes, France; University of Bari, Bari, Italy; Hospital Universitario, Sevilla, Spain; Clinique Neuro Rive-Sud, Greenfield Park, Quebec, Canada; University Hospital La Paz, IdiPAZ, Madrid, Spain; Karadeniz Technical University, Trabzon, Turkey; MS Center, Department of Neuroscience and Imaging, University “G. d’Annunzio”, Chieti, Italy; Hotel-Dieu de Levis, Department of Neurology, Levis, Quebec, Canada; Ospedali Riuniti di Salerno, Salerno, Italy; FLENI, Buenos Aires, Argentina; Centro Internacional de Restauracion Neurologica, Havana, Cuba; Hospital Universitario Virgen de Valme, Seville, Spain; Ospedale di Macerata, Macerata, Italy; John Hunter Hospital, Newcastle, New South Wales, Australia; Hospital Italiano, Buenos Aires, Argentina; New York University Hospital for Joint Diseases, New York, New York, United States of America; Clinic of Neurology Clinical Center, Skopje, Macedonia; Neurological Institute IRCCS Mondino, Pavia, Italy; Cliniques Universitaires Saint-Luc, Brussels, Belgium; Jewish General Hospital, Montreal, Canada; Mater Dei Hospital, Msida, Malta; Flinders University and Medical Centre, Adelaide, South Australia, Australia; HIGA Gral, San Martin La Plata, Argentina; Brain Mind Research Institute, Camperdown, New South Wales, Australia; General Teaching Hospital, Prague, Czech Republic; The Walton Centre for Neurology and Neurosurgery, Liverpool, United Kingdom; Central University Emergency Military Hospital, Bucharest, Romania; Department of Medicine, Melbourne Brain Centre, The University of Melbourne, Victoria, Australia; Department of Neurology, Box Hill Hospital, Monash University, Melbourne, Victoria, Australia","Conceived and designed the experiments: CM TS MT G. Izquierdo FG’M AL PG JLS MR HB. Performed the experiments: CM TS VGJ HB. Analyzed the data: CM TS VGJ HB. Contributed reagents/materials/analysis tools: MT G. Izquierdo FG’M COG CB AL MG PG G. Iuliano MF JACG RFB GG JLS EC JH TPB RB VvP FM NV MS VS MB EH CY CAS MT HB. Wrote the paper: CM TS VGJ HB.","Research Grants: The following authors have received research grants from Bayer Schering: AL, RB & MB; Biogen Dompe: AL & RB; Biogen Idec: MT, FGM, PG & MB; Merck Serono MT, AL, RB & MB; Novartis: MT, FGM, AL, RB & MB; Sanofi Aventis: AL, PG, RB & MB; Teva: FGM & MB. Travel Grants: The following authors have received travel grants from Bayer Schering: AL, VvP & CAS; Biogen Dompe: AL; Biogen Idec: MG, VvP, NV, CY & HB; EMD Serono: MG; Merck Serono: AL, VvP & CY; Novartis: TS, AL, VvP, NV & HB; Sanofi Aventis: AL, VvP & HB; Teva: AL, CY & CAS. Honoraria: The following authors have received honoraria from Bayer Schering: MT, GIz, AL, PG, JLS, JH, RB & MB; Biogen Dompe: AL & RB; Biogen Idec: MT, GIz, MG, PG, JLS, JH, VvP & MB; EMD Serono: MG, PG & FM; Merck Serono: MT, GIz, AL, JLS, JH, RB, & MB; Novartis: GIz, AL, MG, PG, JLS, RB, NV & MB; Sanofi Aventis: MT, GIz, AL, JLS, RB & MB; Teva: GIz, FGM, AL, MG, PG, JH, MB & CAS. Advisory Board Membership: The following authors report sitting on advisory boards for Bayer Schering: COG, AL, MS & CY; Biogen Dompe: AL; Biogen Idec: COG, MG, VvP, MS, CY & HB; Merck Serono: COG, AL, MS & CY; Novartis: FGM, COG, MS, CY & HB; Sanofi Aventis: MS & HB; Teva: COG, MG & CY. FGM also reports receiving research grants from EMD Serono, Genzyme, ONO & UBC. COG has participated in clinical trials and other research projects promoted by Biogen-Idec, GSK, Teva & Novartis. AL has received travel and research grants from the Associazione Italiana Sclerosi Multipla and is a Consultant of “Fondazione Cesare Serono”. FM has participated in MS clinical trials sponsored by EMD Serono and Bayer. NV has received travel support from Eisai & GSK. EH acknowledges financial support from the Czech Ministry of Education (research program MSM 0021620849). CY reports sitting on the scientific advisory board of Lilly. CY participates in clinical trials sponsored by Biogen Idec, Merck Serono, Novartis, Roche, Sanofi Aventis, and Teva. CY holds research grants from the MS Society United Kingdom, the MND association United Kingdom and the British Polio Fellowship. CY is on the steering committee for LiCALS. HB serves on steering committees for trials conducted by Merck Serono, Biogen Idec and Novartis. HB has received research support from Merck Serono, Novartis and Biogen Idec in his capacity as honorary chair of the MSBase Foundation. HB is the recipient of an National Health and Medical Research Council (NHMRC) Career Development Award (628856), NHMRC Project Grants (566513, 628799, 1009757), NHMRC Centre of Excellence Award (1001216), an ARC Linkage Grant (LP110100473)RG & a National MS Society (United States of America) Project Grant (RG3850A3/1). These disclosures do not alter the authors’ adherence to all the PLoS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.","2012","06","Claire Meyniel","CM",34,TRUE,4,4,4,4,TRUE,TRUE,TRUE,19,"8;9;13;15;17;18;19;20;21;22;23;24;25;26;27;28;29;30;32",TRUE
